UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2017-12, Vol.46 (11-12), p.1037-1053

2017

Volltextzugriff (PDF)

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (7), p.867-879

2015

Volltextzugriff (PDF)

Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (3), p.294-302

2013

Volltextzugriff (PDF)

Review article: acute severe ulcerative colitis – evidence‐based consensus statements

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.127-144

2016

Volltextzugriff (PDF)

Drain fluid amylase as a sensitive biomarker for the early detection of anastomotic leakage in ileal pouch surgery

Colorectal disease, 2019-04, Vol.21 (4), p.460-464

2019

Volltextzugriff (PDF)

Editorial: first among Equals—not for either infliximab or adalimumab in Crohn's disease—yet

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1225-1226

2018

Volltextzugriff (PDF)

Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet?

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.630-631

2017

Volltextzugriff (PDF)

Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort – authors’ reply

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (6), p.856-857

2017

Volltextzugriff (PDF)

Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data

Human molecular genetics, 2014-09, Vol.23 (17), p.4710-4720

2014

Volltextzugriff (PDF)

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (4), p.542-552

2017

Volltextzugriff (PDF)

CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial

Gut, 2004-10, Vol.53 (10), p.1485-1493

2004

Volltextzugriff (PDF)

Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease

Internal medicine journal, 2014-05, Vol.44 (5), p.490-496

2014

Volltextzugriff (PDF)

Commentary: salvage medical therapy for acute severe colitis – ciclosporin or infliximab? Author's reply

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (8), p.989-989

2013

Volltextzugriff (PDF)

Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status

Gut, 2001-03, Vol.48 (3), p.360-366

2001

Volltextzugriff (PDF)

TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s disease

Journal of medical genetics, 2005-06, Vol.42 (6), p.523-528

2005

Volltextzugriff (PDF)

Letter: ciclosporin or infliximab in acute ulcerative colitis ‐ still undecided; authors’ reply

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (8), p.993-993

2013

Volltextzugriff (PDF)

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases

Gut, 2004-07, Vol.53 (7), p.973-979

2004

Volltextzugriff (PDF)

Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy

Colorectal disease, 2013-03, Vol.15 (3), p.374-379

2013

Volltextzugriff (PDF)

Effect of Intestinal Resection on Quality of Life in Crohn’s Disease

Journal of Crohn's and colitis, 2015-06, Vol.9 (6), p.452-462

2015

Volltextzugriff (PDF)

Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease

Gut, 2008-07, Vol.57 (7), p.903-910

2008

Volltextzugriff (PDF)

Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain

Gut, 2018-02, Vol.67 (2), p.393-394

2018

Volltextzugriff (PDF)

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus

Endoscopy, 2009-07, Vol.41 (7), p.618-637

2009

Volltextzugriff (PDF)

CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (5), p.617-628

2006

Volltextzugriff (PDF)

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation

Mucosal immunology, 2017-09, Vol.10 (5), p.1224-1236

2017

Volltextzugriff (PDF)

Comparison of the efficacy and safety of Eudragit‐L‐coated mesalazine tablets with ethylcellulose‐coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (7), p.1017-1026

2006

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(149)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(76)
Humans
(75)
Male
(44)
Female
(43)
Gastroenterology & Hepatology
(42)
Adult
(32)
Inflammatory Bowel Disease
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Middle Aged
(27)
Gastroenterology. Liver. Pancreas. Abdomen
(23)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(23)
Other Diseases. Semiology
(18)
Aged
(16)
Ulcerative Colitis
(15)
Crohn's Disease
(14)
Genetics & Heredity
(14)
Medicin Och Hälsovetenskap
(14)
Risk Factors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis

Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab

Review article: acute severe ulcerative colitis – evidence‐based consensus statements

Drain fluid amylase as a sensitive biomarker for the early detection of anastomotic leakage in ileal pouch surgery

Editorial: first among Equals—not for either infliximab or adalimumab in Crohn's disease—yet

Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet?

Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort – authors’ reply

Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial

Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease

Commentary: salvage medical therapy for acute severe colitis – ciclosporin or infliximab? Author's reply

Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status

TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s disease

Letter: ciclosporin or infliximab in acute ulcerative colitis ‐ still undecided; authors’ reply

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases

Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy

Effect of Intestinal Resection on Quality of Life in Crohn’s Disease

Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease

Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus

CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation

Comparison of the efficacy and safety of Eudragit‐L‐coated mesalazine tablets with ethylcellulose‐coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

Suchergebnisse filtern